BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15670871)

  • 1. Role of third extracellular domain of plasma membrane Ca2+-Mg2+-ATPase based on the novel inhibitor caloxin 3A1.
    Pande J; Mallhi KK; Grover AK
    Cell Calcium; 2005 Mar; 37(3):245-50. PubMed ID: 15670871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel plasma membrane Ca(2+)-pump inhibitor: caloxin 1A1.
    Pande J; Mallhi KK; Grover AK
    Eur J Pharmacol; 2005 Jan; 508(1-3):1-6. PubMed ID: 15680248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caloxin 1b3: a novel plasma membrane Ca(2+)-pump isoform 1 selective inhibitor that increases cytosolic Ca(2+) in endothelial cells.
    Szewczyk MM; Pande J; Akolkar G; Grover AK
    Cell Calcium; 2010 Dec; 48(6):352-7. PubMed ID: 21093050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caloxin: a novel plasma membrane Ca2+ pump inhibitor.
    Chaudhary J; Walia M; Matharu J; Escher E; Grover AK
    Am J Physiol Cell Physiol; 2001 Apr; 280(4):C1027-30. PubMed ID: 11245619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the novel plasma membrane Ca(2+)-pump inhibitor caloxin.
    Holmes ME; Chaudhary J; Grover AK
    Cell Calcium; 2003 Apr; 33(4):241-5. PubMed ID: 12618144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic smooth muscle and endothelial plasma membrane Ca2+ pump isoforms are inhibited differently by the extracellular inhibitor caloxin 1b1.
    Pande J; Mallhi KK; Sawh A; Szewczyk MM; Simpson F; Grover AK
    Am J Physiol Cell Physiol; 2006 May; 290(5):C1341-9. PubMed ID: 16452157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of caloxin 1c2, a novel engineered selective inhibitor of plasma membrane Ca(2+)-pump isoform 4, on coronary artery.
    Pande J; Szewczyk MM; Kuszczak I; Grover S; Escher E; Grover AK
    J Cell Mol Med; 2008 Jun; 12(3):1049-60. PubMed ID: 18494944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-molecule characterization of the dynamics of calmodulin bound to oxidatively modified plasma-membrane Ca2+-ATPase.
    Osborn KD; Zaidi A; Urbauer RJ; Michaelis ML; Johnson CK
    Biochemistry; 2005 Aug; 44(33):11074-81. PubMed ID: 16101291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of conserved residues in transmembrane domains 4,6 and 8 causes loss of Ca2+ transport by the plasma membrane Ca2+ pump.
    Guerini D; Foletti D; Vellani F; Carafoli E
    Biochemistry; 1996 Mar; 35(10):3290-6. PubMed ID: 8605166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane Ca(2+)-ATPase (PMCA) translocates to filopodia during platelet activation.
    Dean WL; Whiteheart SW
    Thromb Haemost; 2004 Feb; 91(2):325-33. PubMed ID: 14961161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-steady-state kinetic study of the mechanism of inhibition of the plasma membrane Ca(2+)-ATPase by lanthanum.
    Herscher CJ; Rega AF
    Biochemistry; 1996 Nov; 35(47):14917-22. PubMed ID: 8942656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane Ca2+-ATPase regulates Ca2+ signaling and the proliferation of airway smooth muscle cells.
    Chen YF; Cao J; Zhong JN; Chen X; Cheng M; Yang J; Gao YD
    Eur J Pharmacol; 2014 Oct; 740():733-41. PubMed ID: 24912144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation.
    Di Leva F; Domi T; Fedrizzi L; Lim D; Carafoli E
    Arch Biochem Biophys; 2008 Aug; 476(1):65-74. PubMed ID: 18328800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative inactivation of purified plasma membrane Ca2+-ATPase by hydrogen peroxide and protection by calmodulin.
    Zaidi A; Barŕon L; Sharov VS; Schöneich C; Michaelis EK; Michaelis ML
    Biochemistry; 2003 Oct; 42(41):12001-10. PubMed ID: 14556631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin C/calmodulin chimeras as erythrocyte plasma membrane Ca2+-ATPase activators.
    Fidalgo da Silva E; Freire MM; Barrabin H; Sorenson MM; Tikunova S; Johnson JD; Chandra M; Pearlstone JR; Scofano HM
    Int J Biochem Cell Biol; 2006 Feb; 38(2):209-21. PubMed ID: 16213185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive inactivation of plasma membrane (Ca2++Mg2+)ATPase by Cd2+ in the absence of ATP and reversible inhibition during catalysis.
    Toledo-Maciel A; Gonçalves-Gomes S; de Gouveia Castex M; Vieyra A
    Biochemistry; 1998 Nov; 37(44):15261-5. PubMed ID: 9799486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium extrusion by plasma membrane calcium pump is impaired in caveolin-1 knockout mouse small intestine.
    El-Yazbi AF; Cho WJ; Schulz R; Daniel EE
    Eur J Pharmacol; 2008 Sep; 591(1-3):80-7. PubMed ID: 18634779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural uncoupling between opposing domains of oxidized calmodulin underlies the enhanced binding affinity and inhibition of the plasma membrane Ca-ATPase.
    Chen B; Mayer MU; Squier TC
    Biochemistry; 2005 Mar; 44(12):4737-47. PubMed ID: 15779900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Na/Ca exchange and the plasma membrane Ca2+-ATPase in beta cell function and death.
    Herchuelz A; Kamagate A; Ximenes H; Van Eylen F
    Ann N Y Acad Sci; 2007 Mar; 1099():456-67. PubMed ID: 17446486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside GM2 modulates the erythrocyte Ca2+-ATPase through its binding to the calmodulin-binding domain and its 'receptor'.
    Duan J; Zhang J; Zhao Y; Yang F; Zhang X
    Arch Biochem Biophys; 2006 Oct; 454(2):155-9. PubMed ID: 16962990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.